Insurance does cover many forms of obesity treatment, but the type of coverage depends heavily on your insurance plan, your state, and the specific treatment. Screening and counseling are covered at no cost under most plans thanks to the Affordable Care Act. Bariatric surgery is widely covered when you meet certain criteria. Prescription weight loss medications are where coverage gets complicated, with major gaps especially in Medicare, though that’s changing soon.
What the ACA Requires All Plans to Cover
Under the Affordable Care Act, all Marketplace health plans and most employer-sponsored plans must cover obesity screening and counseling with no copay or coinsurance. This is classified as preventive care, so your insurer cannot charge you out of pocket for it. In practice, this means your doctor can assess your weight, calculate your BMI, and provide basic counseling on diet and lifestyle changes at no cost to you during a covered visit.
What this doesn’t cover is the more intensive side of treatment: medications, surgery, or structured weight management programs. Those fall under separate coverage rules that vary by insurer.
Medicare’s Current Coverage and Its Limits
Medicare covers Intensive Behavioral Therapy (IBT) for beneficiaries with a BMI of 30 or higher. The schedule is structured: one visit per week for the first month, one visit every other week for months two through six, then monthly visits for the second half of the year. There’s a catch, though. To qualify for the monthly visits in months seven through twelve, you need to have lost at least 3 kilograms (about 6.6 pounds) during the first six months. If you haven’t hit that target, you’ll need to wait six months before being reassessed.
These counseling sessions must happen in a primary care setting with a primary care practitioner. A specialist or a standalone counseling program currently doesn’t qualify, which limits options for many beneficiaries.
The Weight Loss Drug Exclusion
Medicare Part D has a statutory exclusion that blocks coverage of drugs used for weight loss or weight management. This dates back to a provision in the Social Security Act that allows exclusion of “agents when used for anorexia, weight loss, or weight gain.” The result: even as newer medications have transformed obesity care, Medicare enrollees have had no access to them through Part D when used solely for weight loss.
This is set to change. CMS announced the BALANCE model, which will negotiate drug pricing directly with manufacturers of GLP-1 medications and extend coverage to Medicare and Medicaid beneficiaries. Medicare Part D beneficiaries are expected to gain access to these drugs through a short-term demonstration starting in July 2026, with the full BALANCE model launching in January 2027. Under the program, eligible beneficiaries would pay $50 per month for their medication. Coverage will depend on whether drug manufacturers, states, and Part D plan sponsors choose to participate, and patients will likely face prior authorization requirements.
Separately, the Treat and Reduce Obesity Act, introduced in Congress in 2023, would permanently expand Medicare coverage by allowing behavioral therapy from non-primary-care providers and adding weight loss drugs to Part D’s covered benefits. As of the most recent session, it had not been enacted.
Medicaid Coverage Varies Wildly by State
Medicaid coverage for obesity medications is inconsistent. In the first quarter of 2023, only 10 of 47 states with public preferred drug lists covered at least one anti-obesity medication, and just 5 states had unrestricted coverage. By contrast, 39 states covered the diabetes versions of the same GLP-1 drugs without restrictions, meaning that if you had a diabetes diagnosis, access was far easier than if your primary issue was obesity.
The BALANCE model is designed to help close this gap. State Medicaid agencies can begin joining the program in May 2026, with CMS negotiating lower drug prices on their behalf. But participation is voluntary, so the state you live in will still determine what’s available to you.
Employer-Sponsored Plans
Employer health plans have the most flexibility in deciding what obesity treatments to cover. Many large employers do cover bariatric surgery and behavioral counseling, but coverage of weight loss medications remains a sticking point because of high costs. Among employers that don’t currently cover obesity medications, 70% said they would consider adding coverage if drug prices came down, according to a survey by the benefits consulting firm WTW. This suggests that the coverage landscape for employer plans could shift quickly if negotiated drug prices drop through programs like BALANCE or increased competition among manufacturers.
If you’re on an employer plan, your best move is to check your plan’s formulary and benefits summary. Look specifically for “anti-obesity medications” or “weight management” in the prescription drug section, and check whether bariatric surgery falls under a separate surgical benefits category.
What Insurers Require for Weight Loss Medications
Even when your plan does cover GLP-1 medications for weight loss, you’ll almost certainly need prior authorization. The criteria follow a common pattern across insurers. A representative policy from Cigna illustrates the typical requirements:
- BMI threshold: A BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, sleep apnea, high cholesterol, heart disease, knee osteoarthritis, or fatty liver disease.
- Prior weight loss attempts: At least three months of documented behavioral modification and dietary restriction before the insurer will approve medication.
- Continued coverage: To keep your prescription covered after the initial authorization period, you typically need to show you’ve lost at least 4% to 5% of your starting body weight, depending on the specific drug.
If you don’t meet the weight loss threshold at your renewal check, your insurer can deny continued coverage of the medication. This makes it important to track your progress and stay in contact with your prescribing provider about documentation.
Bariatric Surgery Coverage
Bariatric surgery has broader insurance coverage than medications. Medicare covers it for beneficiaries with a BMI of 35 or higher who also have at least one obesity-related condition, such as diabetes, hypertension, heart or lung disease, or obstructive sleep apnea. Most private insurers follow similar criteria, though some set the BMI bar at 40 for patients without comorbidities.
Expect a multi-step approval process. Insurers commonly require a psychological evaluation, documentation from your doctor about previous weight loss attempts, nutritional counseling, and sometimes a supervised diet period of three to six months before they’ll authorize the procedure. The surgery itself is generally performed at accredited centers, and your insurer may limit which facilities and surgeons are eligible.
Recovery timelines vary by procedure type, but most patients return to normal activities within two to six weeks. Long-term follow-up visits with your surgical team and nutritionist are typically part of the covered treatment plan.
How to Find Out What Your Plan Covers
The fastest way to get a clear answer is to call the member services number on the back of your insurance card and ask specifically about obesity treatment benefits. Request details on three categories: behavioral counseling or nutrition programs, prescription weight loss medications, and bariatric surgery. For each, ask whether prior authorization is needed and what the approval criteria are.
You can also check your plan’s Summary of Benefits and Coverage document, which insurers are required to provide. Look under preventive services, prescription drug coverage, and surgical benefits. If your plan denies a claim for obesity treatment, you have the right to appeal. Many denials are overturned when proper documentation of medical necessity is submitted by your provider.